Randomized phase II trial comparing molecularly targeted therapy based on tumor molecular profiling versus conventional therapy in patients with refractory cancer: cross-over analysis from the SHIVA trial
Titel:
Randomized phase II trial comparing molecularly targeted therapy based on tumor molecular profiling versus conventional therapy in patients with refractory cancer: cross-over analysis from the SHIVA trial
Auteur:
Belin, L. Kamal, M. Mauborgne, C. Plancher, C. Mulot, F. Delord, J.-P. Gonçalves, A. Gavoille, C. Dubot, C. Isambert, N. Campone, M. Trédan, O. Ricci, F. Alt, M. Loirat, D. Sablin, M.-P. Paoletti, X. Servois, V. Le Tourneau, C.